Sugammadex Impurity 17

Product Description
CAT No.
ALN-S029063
CAS No.
NA
Mol. F.
C73H112O48S8
Mol. Wt.
2014.1
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Smiles : OC(CCSC[C@@H]1[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]4[C@H](O)[C@@H](O)[C@H](O5)[C@@H](CSCCC(O)=O)O4)[C@@H](CSCCC(O)=O)O3)[C@@H](CSCCC(O)=O)O2)[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H]7[C@@H](O[C@@H]8[C@@H](CSCCC(O)=O)O[C@H](O[C@H]9[C@H](O)[C@@H](O)[C@@H](O[C@H]%10[C@H](O)[C@@H](O)[C@@H]5O[C@@H]%10CSCCC(O)=O)O[C@@H]9CSCCC(O)=O)[C@H](O)[C@H]8OCO7)O[C@@H]6CSCCC(O)=O)O1)=O
Inchi : InChI=1S/C18H32N2O3/c19-13-17(7-3-1-4-8-17)11-15(21)20-14-18(12-16(22)23)9-5-2-6-10-18/h1-14,19H2,(H,20,21)(H,22,23)
Technical Data
Reference
Analytical method development and validation for the estimation of sugammadex
By Parekh, Hemangi; Chokshi, Parin; Mashru, RajashreenFrom Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.
Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H – From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.
RFQ